Skip to content

Mescaline: all studies

Page 11 of 97: studies 101 to 110 of 963, newest first. Back to the mescaline overview

Research

Peyote and mescaline exposures: a 12-year review of a statewide poison center database

Clinical Toxicology 2010 Shaun D. Carstairs, F. Lee Cantrell 48 citations

Although uncommonly encountered, use of peyote and mescaline was associated with clinically significant effects requiring treatment in a substantial number of patients. Clinical effects were usually mild or moderate, and life-threatening toxicity was not reported in this case series.

DOI: 10.3109/15563650903586745 (opens in new tab) Mescaline Mydriasis Poison control center Vomiting +2

Novel, Unifying Mechanism for Mescaline in The Central Nervous System: Electrochemistry, Catechol Redox Metabolite, Receptor, Cell Signaling and Structure Activity Relationships

Oxidative Medicine and Cellular Longevity 2009 Peter Kovacic, Ratnasamy Somanathan 34 citations

A unifying mechanism for abused drugs has been proposed previously from the standpoint of electron transfer. Mescaline can be accommodated within the theoretical framework based on redox cycling by the catechol metabolite with its quinone counterpart. Electron transfer may play a role in electrical effects involving the nervous system in the brain. This approach is in accord with structure...

The Native American Church, Peyote, and Health: Expanding Consciousness for Healing Purposes

Contemporary Justice Review December 1, 2007 Peter N. Jones 31 citations

Since the passage of the Comprehensive Drug Abuse Prevention and Control Act of 1970, Native American Church (NAC) members have continually had to defend their legal right to use the sacred cactus peyote (Lophophora williamsii). This legal right was established with the passage of 21 CFR 1307.31, which exempts peyote's Schedule I status for NAC members. The exemption, however, continues to be...

Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose

Psychopharmacology October 6, 2007 Tomáš Páleníček, Marie Balı́ková, Vĕra Bubeníková‐valešová et al. 61 citations

RationaleMescaline is a nonselective serotonin receptor agonist. It has relatively delayed onset of action and prolonged duration. Mescaline attenuates various behavioral parameters in rats; however, no information is available about its pharmacokinetics in rats and its relation to the behavioral changes produced by the drug.ObjectivesThe present study evaluates the spontaneous locomotor...

DOI: 10.1007/s00213-007-0926-5 (opens in new tab) Mescaline Prepulse inhibition Pharmacology Pharmacokinetics +3

Synthesis of the 3-(3,4,5-Trimethoxyphenyl)-pyrrolidine: A New Conformationally Constrained Mescaline Analogue

Synthetic Communications June 1, 2007 Ricardo de L. Barreto, Laura B. L. R. Nascimbem, Carlos Roque D. Correia 8 citations

Abstract The total synthesis of the 3‐(3,4,5-trimethoxyphenyl)-pyrrolidine, a new and conformationally constrained mescaline analogue, was accomplished in a concise and efficient manner. The synthetic route encompassed only 4 steps from the starting N-Cbz-3-pyrrolidine, in 46% overall yield. The route features a highly effective Heck arylation of the non-activated olefin N-Cbz-3-pyrrolidine...

DOI: 10.1080/00397910701356504 (opens in new tab) Mescaline Pyrrolidine Hemiaminal Stereochemistry +3

Palladium-Catalyzed Alkylation-Alkenylation Reactions: Rapid Access to Tricyclic Mescaline Analogues

Synlett October 25, 2006 Mark Lautens, Dino Alberico 10 citations

A norbornene-mediated palladium-catalyzed sequence is described in which two alkyl-aryl bonds and one alkenyl-aryl bond are formed in one pot. A variety of symmetrical and unsymmetrical tricyclic heterocycles were synthesized in good yields from a Heck acceptor and an aryl iodide containing two tethered alkyl bromides. This methodology was applied to the synthesis of a tricyclic mescaline...

C-(4,5,6-Trimethoxyindan-1-yl)methanamine: A Mescaline Analogue Designed Using a Homology Model of the 5-HT2AReceptor

Journal of Medicinal Chemistry June 21, 2006 Thomas H. Mclean, James J. Chambers, Jason C. Parrish et al. 24 citations

A conformationally restricted analogue of mescaline, C-(4,5,6-trimethoxyindan-1-yl)-methanamine, was designed using a 5-HT(2A) receptor homology model. The compound possessed 3-fold higher affinity and potency than and efficacy equal to that of mescaline at the 5-HT(2A) receptor. The new analogue substituted fully for LSD in drug discrimination studies and was 5-fold more potent than mescaline....

DOI: 10.1021/jm060272y (opens in new tab) Mescaline Potency Stereochemistry Homology modeling +8

Mescalina y ritual del cactus de san Pedro: evidencias arqueológicas y etnográficas en el norte de Perú

Revista de Neurología 2006 Francisco Javier Carod-Artal, C Vázquez-cabrera 27 citations

INTRODUCTION: The San Pedro cactus contains the alkaloid mescaline and other derivates of phenethylamine with hallucinogenic properties. This cactus was used throughout history by a number of different pre-Columbine cultures and civilisations that settled in northern Peru. In this article we review the ethno-archaeological and ethno-historical evidence of the ritual use of the San Pedro cactus...